Britain has launched a major genetics research project that aims to address the health disparities affecting South Asian communities through research efforts to improve disease diagnosis, treatment and prevention methods.
The Genes & Health study, led by Queen Mary University of London, is inviting British Pakistani and Bangladeshi residents of Wolverhampton and Walsall to take part.
The Genes & Health study focuses on understanding how genetics influences conditions that affect the South Asian population at higher rates, including diabetes and cardiovascular disease. Researchers say genomic research has not adequately studied these communities, leading to treatment limitations.
Fahad Hossain, consultant and director of research and development at Walsall Manor Hospital, described the study results as having the potential to bring about permanent change. The better scientists understand genes, the more they will improve treatment methods for predicting and diagnosing diseases.
The Genes & Health study requires participants to provide saliva samples for DNA analysis and complete short health questionnaires. Some volunteers may also be invited for further research to deepen research into specific conditions.
The research is being delivered through a partnership between The Royal Wolverhampton NHS Trust and Walsall Healthcare NHS Trust, along with additional partners.
The Genes & Health study stands out as the largest genetics research project conducting research with South Asian communities, according to experts. Tonny Veenith, clinical director of Royal Wolverhampton NHS Trust Research, said that throughout history, genetic studies have mainly examined European populations.
The research will deliver better health outcomes through improved medical representation of South Asian communities. The Genes & Health study will provide critical information researchers need to address persistent health inequities and design better healthcare solutions for generations to come.
